TDP-43 was demonstrated to interact with NF-κB, and an NF-κB inhibitor reduced ALS disease symptoms in a TDP-43 transgenic mouse model (Swarup et al., 2011). The gene discussed is TARDBP; the disease is amyotrophic lateral sclerosis.